Hanseatic Management Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,557
| Closed | -$590K | – | 159 |
|
|
2021
Q4 | $590K | Buy |
4,557
+83
| +2% | +$10.7K | 0.96% | 36 |
|
|
2021
Q3 | $507K | Buy |
+4,474
| New | +$507K | 0.88% | 47 |
|
|
2020
Q3 | – | Sell |
-10,146
| Closed | -$701K | – | 205 |
|
|
2020
Q2 | $701K | Sell |
10,146
-3,597
| -26% | -$249K | 0.59% | 69 |
|
|
2020
Q1 | $864K | Sell |
13,743
-13,698
| -50% | -$861K | 0.92% | 29 |
|
|
2019
Q4 | $2.13M | Buy |
27,441
+12
| +0% | +$933 | 1.95% | 3 |
|
|
2019
Q3 | $2.01M | Buy |
27,429
+7,911
| +41% | +$580K | 2.06% | 5 |
|
|
2019
Q2 | $1.2M | Sell |
19,518
-210
| -1% | -$12.9K | 1.23% | 13 |
|
|
2019
Q1 | $1.26M | Buy |
19,728
+5,769
| +41% | +$368K | 1.31% | 15 |
|
|
2018
Q4 | $713K | Hold |
13,959
| – | – | 0.96% | 33 |
|
|
2018
Q3 | $810K | Hold |
13,959
| – | – | 0.76% | 45 |
|
|
2018
Q2 | $677K | Buy |
+13,959
| New | +$677K | 0.58% | 60 |
|
|
2016
Q4 | – | Sell |
-86,292
| Closed | -$3.47M | – | 331 |
|
|
2016
Q3 | $3.47M | Buy |
86,292
+1,440
| +2% | +$57.9K | 1.24% | 17 |
|
|
2016
Q2 | $2.82M | Buy |
84,852
+20,754
| +32% | +$690K | 1.07% | 22 |
|
|
2016
Q1 | $1.89M | Buy |
64,098
+18,678
| +41% | +$549K | 0.68% | 60 |
|
|
2015
Q4 | $1.2M | Hold |
45,420
| – | – | 0.42% | 84 |
|
|
2015
Q3 | $1.08M | Buy |
45,420
+31,920
| +236% | +$756K | 0.33% | 101 |
|
|
2015
Q2 | $320K | Sell |
13,500
-83,220
| -86% | -$1.97M | 0.14% | 163 |
|
|
2015
Q1 | $2.3M | Buy |
96,720
+840
| +0.9% | +$19.9K | 1.23% | 16 |
|
|
2014
Q4 | $2.04M | Hold |
95,880
| – | – | 1.04% | 25 |
|
|
2014
Q3 | $1.63M | Hold |
95,880
| – | – | 0.87% | 36 |
|
|
2014
Q2 | $1.37M | Buy |
+95,880
| New | +$1.37M | 0.89% | 48 |
|